Interleukin-11 attenuates Ifosfamide-induced hemorrhagic cystitis

International Braz J Urol

Volumn 33, Issue 5, 2007, Pages 704-710

  Mota, Jose M ^a   Brito, Gerly A ^a   Loiola, Raphael T ^a   Cunha, Fernando Q ^a   Ribeiro, Ronaldo de A ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Bladder; Cystitis; Ifosfamide; Interleukin 11; Rats

Indexed keywords

EID: 36549061523     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382007000500013     Document Type: Article

References (20)

1. Neben S, Turner K: The biology of interleukin 11. Stem Cells. 1993; 11: 156-62.
2. Leng SX, Elias JA: Interleukin-11. Int J Biochem Cell Biol. 1997; 29: 1059-62.
3. Basser R: The impact of thrombopoietin on clinical practice. Curr Pharm Des. 2002; 8: 369-77.
4. Sonis ST, Peterson RL, Edwards LJ, Lucey CA, Wang L, Mason L, et al.: Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol. 2000; 36: 373-81.
5. Sonis ST, Van Vugt AG, McDonald J, Dotoli E, Schwertschlag U, Szklut P, et al.: Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters. Cytokine. 1997; 9: 605-12.
6. Cox PJ: Cyclophosphamide cystitis - identification of acrolein as the causative agent. Biochem Pharmacol. 1979; 28: 2045-9.
7. Shepherd JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL: Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol. 1991; 9: 2016-20.
8. Trepicchio WL, Bozza M, Pedneault G, Dorner AJ: Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol. 1996; 157: 3627-34.
9. Orazi A, Du X, Yang Z, Kashai M, Williams DA: Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest. 1996; 75: 33-42.
10. Gray KJ, Engelmann UH, Johnson EH, Fishman IJ: Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (Cytoxan) therapy. J Urol. 1986; 136: 497-500.
11. Souza-Fiho MV, Lima MV, Pompeu MM, Ballejo G, Cunha FQ, Ribeiro Rde A: Involvement of nitric oxide in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis. Am J Pathol. 1997; 150: 247-56.
12. Ribeiro RA, Freitas HC, Campos MC, Santos CC, Figueiredo FC, Brito GA, et al.: Tumor necrosis factor-alpha and interleukin-1beta mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice. J Urol. 2002; 167: 2229-34.
13. Gomes TN, Santos CC, Souza-Filho MV, Cunha FQ, Ribeiro RA: Participation of TNF-alpha and IL-1 in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis. Braz J Med Biol Res. 1995; 28: 1103-8.
14. Vieira MM, Brito GA, Belarmino-Filho JN, Macedo FY, Nery EA, Cunha FQ, et al.: Use of dexamethasone with mesna for the prevention of ifosfamide-induced hemorrhagic cystitis. Int J Urol. 2003; 10: 595-602.
15. Batista CK, Mota JM, Souza ML, Leitao BT, Souza MH, Brito GA, et al.: Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis. Cancer Chemother Pharmacol. 2006; Epub ahead of print.
16. Schwertschlag US, Trepicchio WL, Dykstra KH, Keith JC, Turner KJ, Dorner AJ: Hematopoietic, immunomodulatory and epithelial effects of interleukin-11. Leukemia. 1999; 13: 1307-15.
17. Trepicchio WL, Ozawa M, Walters IB, Kikuchi T, Gilleaudeau P, Bliss JL, et al.: Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions. J Clin Invest. 1999; 104: 1527-37. Erratum in: J Clin Invest 2000; 105: 396.
18. Lgssiar A, Hassan M, Schott-Ohly P, Friesen N, Nicoletti F, Trepicchio WL, et al.: Interleukin-11 inhibits NF-kappaB and AP-1 activation in islets and prevents diabetes induced with streptozotocin in mice. Exp Biol Med (Maywood). 2004; 229: 425-36.
19. Kuenzler KA, Pearson PY, Schwartz MZ: IL-11 pretreatment reduces cell death after intestinal ischemia-reperfusion. J Surg Res. 2002; 108: 268-72.
20. Gibson RJ, Keefe DM, Thompson FM, Clarke JM, Goland GJ, Cummins AG: Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Dig Dis Sci. 2002; 47: 2751-7.